8-K Announcements
6Material company update
May 1, 2026·SEC
Material company update
Apr 30, 2026·SEC
Material company update
Apr 30, 2026·SEC
Ryan Specialty Holdings, Inc.(RYAN)Earnings, Financials & Key Ratios
RYAN•NYSE•Insurance & Managed Care
$29.39
$3.81B mkt cap·62.5× P/E·Price updated May 6, 2026
SectorFinancial ServicesIndustrySpecialty InsuranceSub-IndustryInsurance Distribution and MGA Services
AboutRyan Specialty Group Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company was founded in 2010 and is headquartered in Chicago, Illinois.Show more
- Revenue$3.05B+21.3%
- Combined Ratio79.51%-10.8%
- Net Income$63M-33.0%
- Return on Equity5.39%-40.8%
- Medical Cost Ratio9.42%
- Operating Margin20.49%+89.1%
- Net Margin2.08%-44.8%
- ROA0.63%-44.0%
- Equity / Assets11.87%+4.3%
- Book Value per Share4.50+12.7%
- Tangible BV/Share-7.51+31.8%
- Debt/Equity2.82-10.7%
RYAN Key Insights
Ryan Specialty Holdings, Inc. (RYAN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 79.5% combined ratio
- ✓Low loss ratio of 9.4%
✗Weaknesses
- ✗High debt to equity ratio of 2.8x
- ✗Weak momentum: RS Rating 9 (bottom 9%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
RYAN Price & Volume
Ryan Specialty Holdings, Inc. (RYAN) stock price & volume — 10-year historical chart
Loading chart...
RYAN Growth Metrics
Ryan Specialty Holdings, Inc. (RYAN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years24.54%
3 Years20.93%
TTM18.93%
Profit CAGR
10 Years-
5 Years-1.42%
3 Years1.27%
TTM160.73%
EPS CAGR
10 Years-
5 Years-5.99%
3 Years-3.31%
TTM551.28%
Return on Capital
10 Years4.22%
5 Years3.65%
3 Years4.54%
Last Year6.42%
RYAN Recent Earnings
Ryan Specialty Holdings, Inc. (RYAN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 30, 2026EPS
$0.47
Est $0.43
+9.3%
Revenue
$795M
Est $781M
+1.8%
Q1 2026
Feb 12, 2026EPS
$0.45
Est $0.50
-10.0%
Revenue
$751M
Est $777M
-3.3%
Q4 2025
Oct 30, 2025EPS
$0.47
Est $0.47
+0.0%
Revenue
$755M
Est $777M
-2.9%
Q3 2025
Jul 31, 2025EPS
$0.66
Est $0.66
+0.0%
Revenue
$855M
Est $746M
+14.7%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.47vs $0.43+9.3% | $795Mvs $781M+1.8% |
| Q1 2026 | Feb 12, 2026 | $0.45vs $0.50-10.0% | $751Mvs $777M-3.3% |
| Q4 2025 | Oct 30, 2025 | $0.47vs $0.47+0.0% | $755Mvs $777M-2.9% |
| Q3 2025 | Jul 31, 2025 | $0.66vs $0.66+0.0% | $855Mvs $746M+14.7% |
Based on last 12 quarters of dataView full earnings history →
RYAN Peer Comparison
Ryan Specialty Holdings, Inc. (RYAN) competitors in Insurance Distribution and MGA Services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 BWIN | 1.54B | 20.59 | -41.18 | 9.35% | -2.81% | -3.77% | 1.63 | |
 ACGL | 33.74B | 94.70 | 8.15 | 14.27% | 22.07% | 19.02% | 0.11 | |
 ERIE | 9.86B | 213.56 | 20.11 | 7.17% | 13.2% | 25.03% | ||
 AON | 66.04B | 308.22 | 18.11 | 9.45% | 22.54% | 44.16% | 1.73 | |
 MMC | 85.27B | 174.06 | 21.28 | 7.57% | 15.6% | 26.87% | 1.62 | |
 WTW | 23.8B | 252.41 | 15.52 | -2.24% | 16.84% | 20.77% | 0.86 | |
 GSHD | 972.15M | 41.07 | 39.49 | 16.15% | 7.94% | |||
 SLQT | 211.55M | 1.20 | 90.23 | 15.5% | 4.45% | 13.75% | 0.72 |
Compare RYAN vs Peers
Ryan Specialty Holdings, Inc. (RYAN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RYAN Income Statement
Ryan Specialty Holdings, Inc. (RYAN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Revenue | 765.11M | 1.02B | 1.43B | 1.73B | 2.08B | 2.52B | 3.05B | 3.16B |
| Revenue Growth % | - | 33.09% | 40.71% | 20.41% | 20.42% | 21.09% | 21.28% | 18.93% |
| Medical Costs & Claims | 0 | 0 | 0 | 0 | 0 | 0 | 287.51M | 964.31M |
| Medical Cost Ratio % | 0% | 0% | 0% | 0% | 0% | 0% | 9.42% | 30.55% |
| Gross Profit | 765.11M▲ 0% | 1.02B▲ 33.1% | 1.43B▲ 40.7% | 1.73B▲ 20.4% | 2.08B▲ 20.4% | 2.52B▲ 21.1% | 2.76B▲ 9.9% | 2.19B▲ 0% |
| Gross Margin % | 100% | 100% | 100% | 100% | 100% | 100% | 90.58% | 69.45% |
| Gross Profit Growth % | - | 33.09% | 40.71% | 20.41% | 20.42% | 21.09% | 9.85% | - |
| Operating Expenses | 697.13M | 938.81M | 1.37B | 1.55B | 1.84B | 2.24B | 2.14B | 1.67B |
| OpEx / Revenue % | 91.11% | 92.2% | 95.7% | 89.61% | 88.55% | 89.17% | 70.08% | 52.88% |
| Depreciation & Amortization | 53.1M | 67.5M | 112.68M | 109.29M | 115.84M | 167.63M | 287.51M | 219.89M |
| Combined Ratio % | 91.11% | 92.2% | 95.7% | 89.61% | 88.55% | 89.17% | 79.51% | 83.43% |
| Operating Income | 67.98M▲ 0% | 79.47M▲ 16.9% | 61.56M▼ 22.5% | 179.19M▲ 191.1% | 237.93M▲ 32.8% | 272.55M▲ 14.6% | 625.23M▲ 129.4% | 522.87M▲ 0% |
| Operating Margin % | 8.89% | 7.8% | 4.3% | 10.39% | 11.45% | 10.83% | 20.49% | 16.57% |
| Operating Income Growth % | - | 16.89% | -22.53% | 191.07% | 32.78% | 14.55% | 129.4% | - |
| EBITDA | 121.08M | 146.97M | 174.25M | 288.48M | 353.76M | 440.18M | 912.75M | 742.76M |
| EBITDA Margin % | 15.83% | 14.43% | 12.16% | 16.72% | 17.03% | 17.5% | 29.92% | 23.53% |
| Interest Expense | 35.55M | 47.24M | 79.35M | 104.83M | 119.51M | 158.45M | 222.38M | 221.61M |
| Non-Operating Income | -35.55M | -47.24M | -79.35M | -104.83M | -119.51M | -158.45M | 109.66M | 15.94M |
| Pretax Income | 67.98M▲ 0% | 79.47M▲ 16.9% | 61.56M▼ 22.5% | 179.19M▲ 191.1% | 237.93M▲ 32.8% | 272.55M▲ 14.6% | 293.18M▲ 7.6% | 289.25M▲ 0% |
| Pretax Margin % | 8.89% | 7.8% | 4.3% | 10.39% | 11.45% | 10.83% | 9.61% | 9.16% |
| Income Tax | 4.93M | 8.95M | 4.93M | 15.94M | 43.45M | 42.64M | 79.03M | 30.11M |
| Effective Tax Rate % | 7.25% | 11.27% | 8.01% | 8.89% | 18.26% | 15.64% | 26.95% | 10.41% |
| Net Income | 64.17M▲ 0% | 68.1M▲ 6.1% | 65.87M▼ 3.3% | 61.05M▼ 7.3% | 61.04M▼ 0.0% | 94.67M▲ 55.1% | 63.4M▼ 33.0% | 131.64M▲ 0% |
| Net Margin % | 8.39% | 6.69% | 4.6% | 3.54% | 2.94% | 3.76% | 2.08% | 4.17% |
| Net Income Growth % | - | 6.14% | -3.28% | -7.32% | -0.02% | 55.09% | -33.03% | 160.73% |
| EPS (Diluted) | 0.60▲ 0% | 0.64▲ 6.7% | -0.07▼ 110.9% | 0.52▲ 842.9% | 0.52▲ 0.0% | 0.71▲ 36.5% | 0.47▼ 33.8% | 1.02▲ 0% |
| EPS Growth % | - | 6.67% | -110.94% | 842.86% | 0% | 36.54% | -33.8% | 551.28% |
| EPS (Basic) | 0.60 | 0.64 | -0.07 | 0.56 | 0.57 | 0.78 | 0.50 | - |
| Diluted Shares Outstanding | 106.49M | 106.49M | 105.73M | 265.75M | 125.75M | 274.84M | 278.51M | 129.6M |
RYAN Balance Sheet
Ryan Specialty Holdings, Inc. (RYAN) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2.19B | 4.53B | 5.46B | 6.38B | 7.25B | 9.65B | 10.56B | 11.01B |
| Asset Growth % | - | 106.79% | 20.52% | 16.95% | 13.53% | 33.15% | 9.47% | 65.46% |
| Total Investment Assets | 22.52M | 47.22M | 45.42M | 38.51M | 46.1M | 84.81M | 109.98M | 4M |
| Long-Term Investments | 22.52M | 47.22M | 45.42M | 38.51M | 46.1M | 70.88M | 109.98M | 424.26M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 13.94M | 0 | 0 |
| Total Current Assets | 1.42B | 0 | 3.04B | 3.91B | 4.35B | 4.81B | 647.27M | 5.58B |
| Cash & Equivalents | 52.02M | 312.65M | 386.96M | 992.72M | 838.79M | 540.2M | 158.32M | 154.65M |
| Receivables | 127.14M | 2.16B | 2.6B | 2.87B | 3.46B | 4.17B | 488.95M | 10.31B |
| Other Current Assets | 1.22B | -2.51B | 0 | 0 | 0 | 0 | -76.55M | 4.86B |
| Goodwill & Intangibles | 693.75M | 1.83B | 1.88B | 1.8B | 2.26B | 4.12B | 3.34B | 16.16B |
| Goodwill | 528.51M | 1.22B | 1.31B | 1.31B | 1.65B | 2.65B | 3.23B | 3.22B |
| Intangible Assets | 165.24M | 604.76M | 573.93M | 486.44M | 610.67M | 1.48B | 119.62M | 127.05M |
| PP&E (Net) | 11.56M | 111.36M | 100.16M | 175.14M | 170.13M | 183.47M | 199.94M | 191.94M |
| Other Assets | 41.26M | -1.99B | 10.79M | 56.99M | 39.31M | 18.59M | 5.95B | 1.47B |
| Total Liabilities | 2.13B | 4.46B | 4.86B | 5.57B | 6.27B | 8.55B | 9.31B | 9.79B |
| Total Debt | 669.27M | 1.69B | 1.68B | 2.16B | 2.16B | 3.46B | 3.53B | 3.74B |
| Net Debt | 617.26M | 1.38B | 1.3B | 1.16B | 1.32B | 2.92B | 3.37B | 3.59B |
| Long-Term Debt | 660.03M | 1.57B | 1.57B | 1.95B | 1.94B | 3.23B | 3.29B | 3.68B |
| Short-Term Debt | 9.25M | 19.16M | 23.47M | 30.59M | 35.38M | 51.73M | 60.19M | 62.55M |
| Total Current Liabilities | 1.43B | 0 | 433.56M | 414.31M | 501.28M | 649.45M | 86.17M | 5.46B |
| Accounts Payable | 45.93M | 0 | 0 | 0 | 0 | 0 | 217.3M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.22B | -39.04M | 631K | 562K | 55K | 39.92M | -217.3M | 5.39B |
| Deferred Taxes | 0 | 577K | 631K | 562K | 55K | 1000K | 1000K | 176.17M |
| Other Liabilities | 39.23M | -1.65B | 2.79B | 3.05B | 3.67B | 4.47B | 5.73B | 609.16M |
| Total Equity | 63.15M▲ 0% | 71.09M▲ 12.6% | 594.78M▲ 736.7% | 817.81M▲ 37.5% | 979.64M▲ 19.8% | 1.1B▲ 12.1% | 1.25B▲ 14.2% | 1.22B▲ 0% |
| Equity Growth % | - | 12.56% | 736.65% | 37.5% | 19.79% | 12.11% | 14.18% | 51.46% |
| Shareholders Equity | 64.26M | 69.79M | 343.77M | 478.4M | 559.75M | 627.66M | 648.07M | 636.2M |
| Minority Interest | -1.11M | 1.3M | 251M | 339.41M | 419.89M | 470.62M | 605.98M | 582.85M |
| Retained Earnings | -173.75M | 0 | -7.06M | 53.99M | 114.42M | 122.94M | 120.35M | 120.53M |
| Common Stock | 97.5M | 0 | 259K | 259K | 261K | 261K | 265K | 263K |
| Accumulated OCI | 864K | 2.7M | 1.71M | 6.04M | 3.08M | -1.8M | 13.85M | 9.39M |
| Return on Equity (ROE) | 101.6% | 101.46% | 19.79% | 8.64% | 6.79% | 9.11% | 5.39% | 10.77% |
| Return on Assets (ROA) | 2.93% | 2.03% | 1.32% | 1.03% | 0.9% | 1.12% | 0.63% | 1.25% |
| Equity / Assets | 2.88% | 1.57% | 10.9% | 12.81% | 13.52% | 11.38% | 11.87% | 11.07% |
| Debt / Equity | 10.60x | 23.76x | 2.83x | 2.64x | 2.20x | 3.15x | 2.82x | 2.82x |
| Book Value per Share | 0.59 | 0.67 | 5.63 | 3.08 | 7.79 | 4.00 | 4.50 | 9.41 |
| Tangible BV per Share | -5.92 | -16.51 | -12.19 | -3.70 | -10.16 | -11.00 | -7.51 | -16.40 |
RYAN Cash Flow Statement
Ryan Specialty Holdings, Inc. (RYAN) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 149.51M | 135.39M | 273.49M | 335.51M | 477.2M | 514.87M | 643.67M | 643.67M |
| Operating CF Growth % | - | -9.44% | 102% | 22.68% | 42.23% | 7.89% | 25.02% | 82.81% |
| Operating CF / Revenue % | 19.54% | 13.3% | 19.09% | 19.45% | 22.97% | 20.47% | 21.1% | 20.39% |
| Net Income | 63.06M | 70.51M | 56.63M | 163.26M | 194.48M | 229.91M | 214.16M | 131.64M |
| Depreciation & Amortization | 53.1M | 67.5M | 112.68M | 109.29M | 115.84M | 167.63M | 287.51M | 298.38M |
| Stock-Based Compensation | 8.15M | 10.8M | 67.53M | 77.48M | 69.74M | 79M | 38.78M | 63.28M |
| Deferred Taxes | -800K | 203K | -1.15M | 14.54M | 36.66M | 24.22M | 26.05M | 12.54M |
| Other Non-Cash Items | 5.56M | 27.89M | 67.23M | 45.94M | 22.59M | 43.49M | 114.45M | -240.47M |
| Working Capital Changes | 20.44M | -41.51M | -29.44M | -74.99M | 37.9M | -29.38M | -37.28M | 249.47M |
| Cash from Investing | -148M | -768.51M | -457.94M | -22.42M | -476.23M | -1.76B | -834.01M | -274.24M |
| Capital Expenditures | -7.99M | -12.5M | -9.78M | -15.04M | -29.78M | -47M | -67.95M | -64.49M |
| Acquisitions | -144.4M | -741.46M | -108.88M | 0 | -446.68M | -1.71B | -746.49M | -190.84M |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -16.56M | -16.64M |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | 4.39M | -14.55M | -339.27M | -7.38M | 228K | 0 | -3.01M | -2.27M |
| Cash from Financing | 62.27M | 1.13B | 429.28M | 314.76M | -12.61M | 1.17B | 78.12M | -172.44M |
| Dividends Paid | -72.29M | -50.12M | -47.1M | -39.88M | -71.67M | -80.24M | -62.34M | -64.06M |
| Share Repurchases | -3.17M | -52.56M | -967.85M | -7.17M | -8.79M | -27.46M | -3.73M | -41.01M |
| Stock Issued | 0 | 0 | 1.45B | 0 | 0 | 0 | 0 | -164K |
| Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K | -3M |
| Other Financing | 58.91M | 176.2M | 92.12M | -15.66M | 12.68M | -37.55M | 89.79M | 271.09M |
| Net Change in Cash | 64.05M▲ 0% | 493.54M▲ 670.6% | 243.96M▼ 50.6% | 627.72M▲ 157.3% | -11.05M▼ 101.8% | -75.53M▼ 583.3% | -96.33M▼ 27.6% | 173.02M▲ 0% |
| Exchange Rate Effect | 265K | 1.35M | -883K | -126K | 584K | -1.51M | 15.89M | 623K |
| Cash at Beginning | 338.11M | 402.16M | 895.7M | 1.14B | 1.77B | 1.76B | 1.68B | 1.58B |
| Cash at End | 402.16M | 895.7M | 1.14B | 1.77B | 1.76B | 1.68B | 1.58B | 1.48B |
| Free Cash Flow | 141.52M▲ 0% | 122.89M▼ 13.2% | 263.71M▲ 114.6% | 320.47M▲ 21.5% | 447.43M▲ 39.6% | 467.87M▲ 4.6% | 575.71M▲ 23.1% | 554.59M▲ 0% |
| FCF Growth % | - | -13.16% | 114.58% | 21.52% | 39.62% | 4.57% | 23.05% | 28.24% |
| FCF Margin % | 18.5% | 12.07% | 18.41% | 18.58% | 21.54% | 18.6% | 18.87% | 17.57% |
| FCF per Share | 1.33 | 1.15 | 2.49 | 1.21 | 3.56 | 1.7 | 2.07 | 2.07 |
RYAN Key Ratios
Ryan Specialty Holdings, Inc. (RYAN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Combined Ratio | 92.2% | 95.7% | 89.61% | 88.55% | 89.17% | 79.51% | 83.43% |
| Medical Cost Ratio | 0% | 0% | 0% | 0% | 0% | 9.42% | 30.55% |
| Return on Equity (ROE) | 101.46% | 19.79% | 8.64% | 6.79% | 9.11% | 5.39% | 10.77% |
| Return on Assets (ROA) | 2.03% | 1.32% | 1.03% | 0.9% | 1.12% | 0.63% | 1.25% |
| Equity / Assets | 1.57% | 10.9% | 12.81% | 13.52% | 11.38% | 11.87% | 11.07% |
| Book Value / Share | 0.67 | 5.63 | 3.08 | 7.79 | 4 | 4.5 | 9.41 |
| Debt / Equity | 23.76x | 2.83x | 2.64x | 2.20x | 3.15x | 2.82x | 2.82x |
| Revenue Growth | 33.09% | 40.71% | 20.41% | 20.42% | 21.09% | 21.28% | 18.93% |
RYAN SEC Filings & Documents
Ryan Specialty Holdings, Inc. (RYAN) SEC filings — annual & quarterly reports (10-K, 10-Q)
RYAN Frequently Asked Questions
Ryan Specialty Holdings, Inc. (RYAN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Ryan Specialty Holdings, Inc. (RYAN) grew revenue by 21.3% over the past year. This is strong growth.
Yes, Ryan Specialty Holdings, Inc. (RYAN) is profitable, generating $131.6M in net income for fiscal year 2025 (2.1% net margin).
Dividend & Returns
Yes, Ryan Specialty Holdings, Inc. (RYAN) pays a dividend with a yield of 0.76%. This makes it attractive for income-focused investors.
Ryan Specialty Holdings, Inc. (RYAN) has a return on equity (ROE) of 5.4%. This is below average, suggesting room for improvement.
Industry Metrics
Ryan Specialty Holdings, Inc. (RYAN) has a combined ratio of 79.5%. A ratio below 100% indicates underwriting profitability.
Explore More RYAN
Ryan Specialty Holdings, Inc. (RYAN) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates